Abstract
Impaired lung function is predictive of mortality and is a key component in the diagnosis of chronic obstructive pulmonary disease. Lung function has a strong genetic component but is also affected by environmental factors such as increased exposure to air pollution. How genetic factors and air pollution interact to affect lung function is however less understood.
We conducted a genome-wide gene-air pollution interaction analysis of spirometry measures with three measures of air pollution at home address: particulate matter (PM2.5 & PM10) and nitrogen dioxide (NO2), in approximately 300,000 unrelated European individuals from UK Biobank. We explored air pollution interactions with previously identified lung function signals and determined their combined interaction effect using a polygenic risk score (PRS).
We identified seven genome-wide interaction signals (P < 5 × 10−8), and a further ten suggestive interaction signals (P < 5 × 10−7). We found statistical evidence of interaction with PM2.5 for previous lung function signal, rs10841302, near AEBP2, suggesting increased susceptibility of FEV1/FVC to PM2.5, as copies of the G allele increased (interaction beta: −0.073 percentage points, 95%CI: −0.105, −0.041). There was no observed interaction between air pollutants and the weighted genetic risk score.
We carried out the largest genome-wide gene-air pollution interaction study of lung function and identified effects of clinically relevant size and significance. We observed up to 440ml lower lung function for certain genotypes associated with mean levels of outdoor air pollution at baseline, which is approximately equivalent to nine years of normal loss of lung function.
Competing Interest Statement
Martin Tobin and Louise Wain have research collaborations with GSK and with Orion Pharma unrelated to this paper.
Funding Statement
L. Wain holds a GSK/British Lung Foundation Chair in Respiratory Research (C17-1). The research was partially supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health.
M. Tobin is supported by a Wellcome Trust Investigator Award (WT202849/Z/16/Z) and holds an NIHR Senior Investigator Award.
Anna Hansell acknowledges funding from the Health Protection Research Unit in Environmental Exposures and Health, a partnership between Public Health England, the Health and Safety Executive and the University of Leicester. The views expressed are those of the authors and not necessarily those of the NHS the NIHR, Public Health England, the Health and Safety Executive or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC), which covers the UK. For more information visit: https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics
This research was undertaken using UK Biobank application 648.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data will be made available following peer review.
